Skip to main content
Top
Published in: Pituitary 4/2011

01-12-2011

Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL

Authors: S. Cannavò, R. Condurso, M. Ragonese, F. Ferraù, A. Alibrandi, I. Aricò, G. Romanello, S. Squadrito, F. Trimarchi, R. Silvestri

Published in: Pituitary | Issue 4/2011

Login to get access

Abstract

Restless legs syndrome (RLS), a neurological sensory-motor disorder characterized by a compelling urge to move the limbs during the night, is a sleep disturbance that impairs quality of life. Prevalence of RLS and consequences on quality of life were investigated in acromegalic patients. Fifty-six patients (20 men, 55.0 ± 1.6 years), 22 with active acromegaly (group 1) and 34 with controlled disease (group 2), and 95 controls (35 men, 52.9 ± 1.1 years) were evaluated by a structured sleep interview concerning insomnia, circadian sleep disorders and excessive diurnal sleepiness (EDS). The Epworth Sleepiness Scale (ESS) questionnaire was administered to those reporting EDS. Patients were investigated by RLS diagnostic interview and International Restless Leg SyndromeRating Scale (IRLS-RS). Quality of life was investigated by AcroQoL questionnaire. RLS was diagnosed in 21% of acromegalics and in 4% of controls (P < 0.002). Prevalence of RLS and mean IRLS-RS was higher in group 1 than in group 2 (P < 0.05). Prevalence of insomnia (P < 0.0002) and of EDS (P < 0.05) and mean ESS score (P < 0.01) were higher in RLS-positive than in RLS-free acromegalics. Video-PSG showed that mean sleep latency (P < 0.01), micro-arousal index (P < 0.05) and wakefulness after sleep onset (P < 0.01) were higher, whereas sleep efficiency (P < 0.01) was lower, in RLS-positive than in RLS-free patients. Global and physical AcroQoL scores were significantly lower in RLS-positive than in RLS-free acromegalics (P < 0.01 and P < 0.001, respectively). Prevalence and severity of RLS is increased in patients with active acromegaly and impacts negatively on their physical performances, dramatically impairing quality of life.
Literature
1.
go back to reference Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of Life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341PubMedCrossRef Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of Life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337–3341PubMedCrossRef
2.
go back to reference Pantanetti P, Sonino N, Arnaldi G, Boscaro M (2002) Self image and quality of life in acromegaly. Pituitary 5:17–19PubMedCrossRef Pantanetti P, Sonino N, Arnaldi G, Boscaro M (2002) Self image and quality of life in acromegaly. Pituitary 5:17–19PubMedCrossRef
3.
go back to reference Webb SM, Badia X, Surinach NL, SpanishAcroQolStudy Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269–277PubMedCrossRef Webb SM, Badia X, Surinach NL, SpanishAcroQolStudy Group (2006) Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269–277PubMedCrossRef
4.
go back to reference Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731–2739PubMedCrossRef Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731–2739PubMedCrossRef
5.
go back to reference Barrière G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I (2005) The restless legs syndrome. Prog Neurobiol 77:139–165PubMedCrossRef Barrière G, Cazalets JR, Bioulac B, Tison F, Ghorayeb I (2005) The restless legs syndrome. Prog Neurobiol 77:139–165PubMedCrossRef
6.
go back to reference Walters AS, Rye DB (2009) Review of the relationship of restless legs syndrome and periodic limbs movements in sleep to hypertension, heart disease and stroke. Sleep 32:589–597PubMed Walters AS, Rye DB (2009) Review of the relationship of restless legs syndrome and periodic limbs movements in sleep to hypertension, heart disease and stroke. Sleep 32:589–597PubMed
7.
go back to reference Walters AS, Rye DB (2010) Evidence continue to mount on the relationship of restless legs syndrome/periodic limb movements in sleep to hypertension, cardiovascular disease and stroke. Sleep 33(3):287PubMed Walters AS, Rye DB (2010) Evidence continue to mount on the relationship of restless legs syndrome/periodic limb movements in sleep to hypertension, cardiovascular disease and stroke. Sleep 33(3):287PubMed
8.
go back to reference Johns MW (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. The epworth sleepiness scale. Chest 103:30–36PubMedCrossRef Johns MW (1993) Daytime sleepiness, snoring, and obstructive sleep apnea. The epworth sleepiness scale. Chest 103:30–36PubMedCrossRef
9.
go back to reference Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119PubMedCrossRef Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119PubMedCrossRef
10.
go back to reference Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group (2003) Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4:121–132PubMedCrossRef Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group (2003) Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 4:121–132PubMedCrossRef
11.
go back to reference Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly quality of life questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 57:251–258CrossRef Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly quality of life questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol 57:251–258CrossRef
12.
go back to reference Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Int Med 165:1286–1292CrossRef Allen RP, Walters AS, Montplaisir J, Hening W, Myers A, Bell TJ, Ferini-Strambi L (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Int Med 165:1286–1292CrossRef
13.
go back to reference Machtey I (2001) Epidemiology of restless legs syndrome. Arch Int Med 161:483–484CrossRef Machtey I (2001) Epidemiology of restless legs syndrome. Arch Int Med 161:483–484CrossRef
14.
go back to reference Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, Kaleagasi H, Aral M, Helvaci I (2003) Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 61:1562–1569PubMed Sevim S, Dogu O, Camdeviren H, Bugdayci R, Sasmaz T, Kaleagasi H, Aral M, Helvaci I (2003) Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 61:1562–1569PubMed
15.
go back to reference Bjorvatn B, Leissner L, Ulfberg J, Gyring J, Karlsborg M, Regeur L, Skeidsvoll H, Nordhus IH, Pallesen S (2005) Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 6:307–331PubMedCrossRef Bjorvatn B, Leissner L, Ulfberg J, Gyring J, Karlsborg M, Regeur L, Skeidsvoll H, Nordhus IH, Pallesen S (2005) Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 6:307–331PubMedCrossRef
16.
go back to reference Möller C, Wetter TC, Köster J, Stiasny-Kolster K (2010) Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population. Sleep Med 11(2):161–166PubMedCrossRef Möller C, Wetter TC, Köster J, Stiasny-Kolster K (2010) Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population. Sleep Med 11(2):161–166PubMedCrossRef
17.
go back to reference Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B (2009) Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol 15(1):12–15PubMedCrossRef Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B (2009) Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol 15(1):12–15PubMedCrossRef
18.
go back to reference Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G (2003) Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. Eur J Endocrinol 148(1):31–38PubMedCrossRef Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G (2003) Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. Eur J Endocrinol 148(1):31–38PubMedCrossRef
19.
go back to reference Ekbom K (1945) Restless legs: a clinical study. Acta Med Scand 158:1–123 Ekbom K (1945) Restless legs: a clinical study. Acta Med Scand 158:1–123
20.
go back to reference Chabli A, Michaud M, Montplaisir J (2000) Periodic arm movements in patients with the restless legs syndrome. Eur Neurol 44:133–138PubMedCrossRef Chabli A, Michaud M, Montplaisir J (2000) Periodic arm movements in patients with the restless legs syndrome. Eur Neurol 44:133–138PubMedCrossRef
21.
go back to reference Gamaldo C, Benbrook AR, Allen RP, Oguntimein O, Earley CJ (2009) Evaluating daytime alertness in individuals with restless legs syndrome (RLS) compared to sleep restricted controls. Sleep Med 10:134–138PubMedCrossRef Gamaldo C, Benbrook AR, Allen RP, Oguntimein O, Earley CJ (2009) Evaluating daytime alertness in individuals with restless legs syndrome (RLS) compared to sleep restricted controls. Sleep Med 10:134–138PubMedCrossRef
22.
go back to reference Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ (2006) Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 7:25–30PubMedCrossRef Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ (2006) Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 7:25–30PubMedCrossRef
23.
go back to reference Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667–674PubMedCrossRef Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667–674PubMedCrossRef
24.
go back to reference Clemens S, Rye D, Hochman S (2006) Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67(1):125–130PubMedCrossRef Clemens S, Rye D, Hochman S (2006) Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 67(1):125–130PubMedCrossRef
25.
go back to reference Caylak E (2009) The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Gen 149A:2612–2626CrossRef Caylak E (2009) The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Gen 149A:2612–2626CrossRef
26.
go back to reference Silber MH, Richardson JW (2003) Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 78:52–54PubMedCrossRef Silber MH, Richardson JW (2003) Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc 78:52–54PubMedCrossRef
27.
28.
go back to reference Högl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Müller J, Rungger G, Gasperi A, Wenning G, Poewe W (2005) Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 64:1920–1924PubMedCrossRef Högl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Müller J, Rungger G, Gasperi A, Wenning G, Poewe W (2005) Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 64:1920–1924PubMedCrossRef
29.
go back to reference Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C (2008) Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 23:2267–2302PubMedCrossRef Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C (2008) Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 23:2267–2302PubMedCrossRef
Metadata
Title
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL
Authors
S. Cannavò
R. Condurso
M. Ragonese
F. Ferraù
A. Alibrandi
I. Aricò
G. Romanello
S. Squadrito
F. Trimarchi
R. Silvestri
Publication date
01-12-2011
Publisher
Springer US
Published in
Pituitary / Issue 4/2011
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-011-0298-z

Other articles of this Issue 4/2011

Pituitary 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine